Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Parkinson Disease D010300 53 associated lipids
von Willebrand Diseases D014842 2 associated lipids
Ascorbic Acid Deficiency D001206 9 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Atherosclerosis D050197 85 associated lipids
Insulin Resistance D007333 99 associated lipids
Dehydration D003681 11 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Critical Illness D016638 13 associated lipids
Anemia, Iron-Deficiency D018798 6 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Agarwal R Ironing out the mystery of nephrotoxicity of parenteral iron. 2005 J. Lab. Clin. Med. pmid:16025083
Anbu AT et al. Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. 2005 Acta Paediatr. pmid:16431410
Zager RA Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. 2005 Kidney Int. pmid:16164630
Erichsen K et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. 2005 Scand. J. Gastroenterol. pmid:16165718
St Peter WL et al. Trends in intravenous iron use among dialysis patients in the United States (1994-2002). 2005 Am. J. Kidney Dis. pmid:16183420
Ayotte P et al. Biomarker measurements in a coastal fish-eating population environmentally exposed to organochlorines. 2005 Environ. Health Perspect. pmid:16203240
Georgopoulos D et al. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. 2005 Crit Care pmid:16277712
Laman CA et al. Parenteral iron therapy: a single institution's experience over a 5-year period. 2005 J Natl Compr Canc Netw pmid:16316614
Breymann C Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex. 2005 J Med Assoc Thai pmid:17718296
Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited. 2005 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:16360535
Govan AD and Scott JM Intravenous iron in the treatment of anemia of pregnancy. 1949. 2005 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:16360540
Ozdemir A et al. Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients. 2005 Nephrology (Carlton) pmid:16221090
Spiegel K et al. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. 2005 J. Appl. Physiol. pmid:16227462
Aime S et al. para-Hydrogenation of unsaturated moieties on poly(lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents. 2005 Org. Biomol. Chem. pmid:16240012
Schröder O et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. 2005 Am. J. Gastroenterol. pmid:16279906
Sengölge G et al. Intravenous iron therapy: well-tolerated, yet not harmless. 2005 Eur. J. Clin. Invest. pmid:16281958
Agarwal R On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. 2005 Am. J. Physiol. Renal Physiol. pmid:15467003
Al-Mueilo SH Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. 2005 Apr-Jun Saudi J Kidney Dis Transpl pmid:18202490
Pecharki GD et al. Effect of sucrose containing iron (II) on dental biofilm and enamel demineralization in situ. 2005 Mar-Apr Caries Res. pmid:15741724
Cançado RD et al. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia]. 2005 Nov-Dec Rev Assoc Med Bras (1992) pmid:16444338
Davey CL et al. Esterification of select polyols with D-glucaric acid as model reactions for esterification of starch. 2006 Carbohydr. Res. pmid:16973136
Bolger AP et al. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. 2006 J. Am. Coll. Cardiol. pmid:16979010
Kato M et al. Tetranuclear copper(II) complexes bridged by alpha-D-glucose-1-phosphate and incorporation of sugar acids through the Cu4 core structural changes. 2006 Inorg Chem pmid:16903719
García-Erce JA et al. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. 2006 Transfus Med pmid:16999756
Carlini RG et al. Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro. 2006 Nephrol. Dial. Transplant. pmid:16957011
Agarwal R Is i.v. iron really superior in CKD patients not on dialysis? 2006 Kidney Int. pmid:16957750
Coletta AP et al. Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. 2006 Eur. J. Heart Fail. pmid:16887387
Eiselt J et al. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. 2006 Blood Purif. pmid:17077626
Sirken G et al. Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients. 2006 Clin. Nephrol. pmid:17140164
Breborowicz A et al. Iron sucrose induced morphological and functional changes in the rat kidney. 2006 Transl Res pmid:17145571
Schiesser D et al. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. 2006 Nephrol. Dial. Transplant. pmid:16891647
Sudan C et al. Ubiquitous presence of beta-glucuronidase (GUS) in plants and its regulation in some model plants. 2006 Planta pmid:16652220
Koutroubakis IE et al. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study. 2006 Eur J Gastroenterol Hepatol pmid:16538115
Guz G et al. Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients. 2006 Nephrol. Dial. Transplant. pmid:16762960
Barton Pai A et al. Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose. 2006 Am. J. Nephrol. pmid:16809897
Muñoz M et al. Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. 2006 Transfus Med pmid:16623920
Bhandal N and Russell R Intravenous versus oral iron therapy for postpartum anaemia. 2006 BJOG pmid:17004982
Agarwal R Proinflammatory effects of iron sucrose in chronic kidney disease. 2006 Kidney Int. pmid:16609688
Brown SD et al. A gold standard set of mechanistically diverse enzyme superfamilies. 2006 Genome Biol. pmid:16507141
Ranfaing E [Treatments of the martial deficiencies: preparations available in France]. 2006 Nephrol. Ther. pmid:17373280
Singh H et al. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. 2006 Clin J Am Soc Nephrol pmid:17699248
Bishu K and Agarwal R Acute injury with intravenous iron and concerns regarding long-term safety. 2006 Clin J Am Soc Nephrol pmid:17699372
Zager RA Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease. 2006 Clin J Am Soc Nephrol pmid:17699373
Karkouti K et al. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. 2006 Can J Anaesth pmid:16371604
Zheng H et al. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. 2006 Kidney Int. pmid:16395269
Johnson G et al. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. 2006 Eur. J. Nucl. Med. Mol. Imaging pmid:16237571
Sato K [Drug-induced osteomalacia]. 2007 Clin Calcium pmid:17906405
Toblli JE et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. 2007 J. Am. Coll. Cardiol. pmid:17950147
Singh J and Gupta KP Induction of apoptosis by calcium D-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin. 2007 J. Environ. Pathol. Toxicol. Oncol. pmid:17725531
Thomas J and Martinez A Blood conservation in the critically ill. 2007 Am J Health Syst Pharm pmid:17687066